References
1. Packer DL, Mark DB, Robb RA et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest among Patients with Atrial Fibrillation: The CABANA Randomized Clinical Trial. In: JAMA - Journal of the American Medical Association . Vol 321. American Medical Association; 2019:1261-1274. doi:10.1001/jama.2019.0693
2. Packer DL, Kowal RC, Wheelan KR et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: First results of the North American arctic front (STOP AF) pivotal trial. J Am Coll Cardiol . 2013;61(16):1713-1723. doi:10.1016/j.jacc.2012.11.064
3. Steven D, Rostock T, Lutomsky B et al. What is the real atrial fibrillation burden after catheter ablation of atrial fibrillation? A prospective rhythm analysis in pacemaker patients with continuous atrial monitoring. Eur Heart J . 2008;29(8):1037-1042. doi:10.1093/eurheartj/ehn024
4. Nielsen JC, Johannessen A, Raatikainen P et al. Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial.Heart . 2017;103(5):368-376. doi:10.1136/heartjnl-2016-309781
5. Andrade JG, Wells GA, Deyell MW et al. Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation. N Engl J Med . Published online November 16, 2020:NEJMoa2029980. doi:10.1056/NEJMoa2029980
6. Kirchhof P, Camm AJ, Goette A et al. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med . 2020;383(14):1305-1316. doi:10.1056/nejmoa2019422
7. Mark DB, Anstrom KJ, Sheng S et al. Effect of Catheter Ablation vs Medical Therapy on Quality of Life among Patients with Atrial Fibrillation: The CABANA Randomized Clinical Trial. In: JAMA - Journal of the American Medical Association . Vol 321. American Medical Association; 2019:1275-1285. doi:10.1001/jama.2019.0692
8. Blomström-Lundqvist C, Gizurarson S, Schwieler J et al. Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients with Atrial Fibrillation: The CAPTAF Randomized Clinical Trial.JAMA - J Am Med Assoc . 2019;321(11):1059-1068. doi:10.1001/jama.2019.0335
9. Marrouche NF, Brachmann J, Andresen D et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med . 2018;378(5):417-427. doi:10.1056/NEJMoa1707855
10. Di Biase L, Mohanty P, Mohanty S et al. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial. In: Circulation . Vol 133. Lippincott Williams and Wilkins; 2016:1637-1644. doi:10.1161/CIRCULATIONAHA.115.019406
11. Wechselberger S, Kronborg M, Huo Y et al. Continuous monitoring after atrial fibrillation ablation: the LINQ AF study. EP Eur . 2018;20(FI_3):f312-f320. doi:10.1093/europace/euy038
12. Dinshaw L, Schäffer B, Akbulak Ö et al. Long-term efficacy and safety of radiofrequency catheter ablation of atrial fibrillation in patients with cardiac implantable electronic devices and transvenous leads. J Cardiovasc Electrophysiol . 2019;30(5):679-687. doi:10.1111/jce.13890
13. Heeger CH, Tscholl V, Salloum O et al. What is the real recurrence rate after cryoballoon-based pulmonary vein isolation? Lessons from rhythm follow-up based on implanted cardiac devices with continuous atrial monitoring. Hear Rhythm . 2018;15(12):1844-1850. doi:10.1016/j.hrthm.2018.07.016
14. Ferreira‐Martins J, Howard J, Al‐Khayatt B et al. Outcomes of paroxysmal atrial fibrillation ablation studies are affected more by study design and patient mix than ablation technique. J Cardiovasc Electrophysiol . 2018;29(11):1471-1479. doi:10.1111/jce.13745
15. Calkins H, Kuck KH, Cappato R et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design. Hear Rhythm . 2012;9(4):632-696.e21. doi:10.1016/j.hrthm.2011.12.016
16. Mittal S, Movsowitz C, Steinberg JS. Ambulatory external electrocardiographic monitoring: Focus on atrial fibrillation. J Am Coll Cardiol . 2011;58(17):1741-1749. doi:10.1016/j.jacc.2011.07.026
17. Swiryn S, Orlov M V., Benditt DG et al. Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes. Circulation . 2016;134(16):1130-1140. doi:10.1161/CIRCULATIONAHA.115.020252
18. Andrade JG, Champagne J, Dubuc M et al. Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial. Circulation . 2019;140(22):1779-1788. doi:10.1161/CIRCULATIONAHA.119.042622
19. Lohrmann G, Kaplan R, Ziegler PD, Monteiro J, Passman R. Atrial fibrillation ablation success defined by duration of recurrence on cardiac implantable electronic devices. J Cardiovasc Electrophysiol . Published online October 27, 2020:jce.14781. doi:10.1111/jce.14781
20. Kaplan RM, Koehler J, Ziegler PD, Sarkar S, Zweibel S, Passman RS. Stroke risk as a function of atrial fibrillation duration and CHA2DS2-VASc score. Circulation . 2019;140(20):1639-1646. doi:10.1161/CIRCULATIONAHA.119.041303
21. Healey JS, Connolly SJ, Gold MR et al. Subclinical Atrial Fibrillation and the Risk of Stroke. N Engl J Med . 2012;366(2):120-129. doi:10.1056/NEJMoa1105575
22. Glotzer T V., Daoud EG, Wyse DG et al. The Relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk the trends study. Circ Arrhythmia Electrophysiol . 2009;2(5):474-480. doi:10.1161/CIRCEP.109.849638
23. Steinhubl SR, Waalen J, Edwards AM et al. Effect of a home-Based wearable continuous ECG monitoring patch on detection of undiagnosed atrial fibrillation the mSToPS randomized clinical trial. JAMA - J Am Med Assoc . 2018;320(2):146-155. doi:10.1001/jama.2018.8102
24. Capucci A, Santini M, Padeletti L et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol . 2005;46(10):1913-1920. doi:10.1016/j.jacc.2005.07.044
25. Glotzer T V., Daoud EG, Wyse DG et al. The Relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk the trends study. Circ Arrhythmia Electrophysiol . 2009;2(5):474-480. doi:10.1161/CIRCEP.109.849638
26. Healey JS, Connolly SJ, Gold MR et al. Subclinical Atrial Fibrillation and the Risk of Stroke. N Engl J Med . 2012;366(2):120-129. doi:10.1056/nejmoa1105575
27. Van Gelder IC, Healey JS, Crijns HJGM et al. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J . 2017;38(17):1339-1344. doi:10.1093/eurheartj/ehx042
28. Lowres N, Neubeck L, Salkeld G et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies: The SEARCH-AF study.Thromb Haemost . 2014;111(6):1167-1176. doi:10.1160/TH14-03-0231
29. Lau JK, Lowres N, Neubeck L et al. IPhone ECG application for community screening to detect silent atrial fibrillation: A novel technology to prevent stroke. Int J Cardiol . 2013;165(1):193-194. doi:10.1016/j.ijcard.2013.01.220
30. Chan PH, Wong CK, Poh YC et al. Diagnostic Performance of a Smartphone-Based Photoplethysmographic Application for Atrial Fibrillation Screening in a Primary Care Setting. J Am Heart Assoc . 2016;5(7). doi:10.1161/JAHA.116.003428
31. Dörr M, Nohturfft V, Brasier N et al. The WATCH AF Trial: SmartWATCHes for Detection of Atrial Fibrillation. JACC Clin Electrophysiol . 2019;5(2):199-208. doi:10.1016/j.jacep.2018.10.006
32. Yan BP, Lai WHS, Chan CKY et al. Contact-free screening of atrial fibrillation by a smartphone using facial pulsatile photoplethysmographic signals. J Am Heart Assoc . 2018;7(8). doi:10.1161/JAHA.118.008585
33. Perez M V., Mahaffey KW, Hedlin H et al. Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation. N Engl J Med . 2019;381(20):1909-1917. doi:10.1056/nejmoa1901183
34. Wasserlauf J, You C, Patel R, Valys A, Albert D, Passman R. Smartwatch Performance for the Detection and Quantification of Atrial Fibrillation. Circ Arrhythmia Electrophysiol . 2019;12(6). doi:10.1161/CIRCEP.118.006834
35. Turakhia MP, Ziegler PD, Schmitt SK et al. Atrial Fibrillation Burden and Short-Term Risk of Stroke: Case-Crossover Analysis of Continuously Recorded Heart Rhythm from Cardiac Electronic Implanted Devices. Circ Arrhythmia Electrophysiol . 2015;8(5):1040-1047. doi:10.1161/CIRCEP.114.003057